Integrating multiphase MRI surrogates to improve microvascular invasion detection and recurrence risk stratification in HCC
DL-TriFusion represents a reliable, non-invasive biomarker with strong potential for clinical translation. By leveraging routinely available MRI and clinical data, it enables accurate preoperative assessment of microvascular invasion and stratification of recurrence risk. This capability could optimize surgical planning, identify candidates for neoadjuvant or adjuvant therapy, refine surveillance strategies, and reduce unnecessary overtreatment - ultimately supporting personalized management of hepatocellular carcinoma.
Authors
- Li Fan (ORCID: https://orcid.org/0000-0003-4722-3933)
- Yangyang Xie (ORCID: https://orcid.org/0009-0006-1606-3585)
- Gang Ning (ORCID: https://orcid.org/0000-0001-5554-5735)
- Haibo Qu (ORCID: https://orcid.org/0000-0003-4488-4277)
- Ruishan Liu (ORCID: https://orcid.org/0000-0002-7298-0701)
- Lihua Zhuo (ORCID: https://orcid.org/0009-0005-5674-0854)
- Hongwei Li (ORCID: https://orcid.org/0000-0002-6293-1017)
- Jin Zhang (ORCID: https://orcid.org/0009-0009-8082-8142)
- Feng Xu (ORCID: https://orcid.org/0000-0003-0902-2858)
- Xiang Ye (ORCID: https://orcid.org/0000-0002-8694-8710)
- Ping Lin
- Jinming Cao (ORCID: https://orcid.org/0000-0002-8614-7366)
Institutions
- Chengdu Medical College (CN)
- Sichuan University (CN)
- Sir Run Run Shaw Hospital (CN)
- Leshan Normal University (CN)
- West China Second University Hospital of Sichuan University (CN)
- Mianyang Third People's Hospital (CN)
- The Fifth People's Hospital of Anyang (CN)
- Deyang Stomatological Hospital (CN)
- Second People’s Hospital of Yibin (CN)
- Nanchong Central Hospital (CN)
- Zhejiang University (CN)
Publication Details
- Journal
- JHEP Reports
- Published
- 2025-11-21
- DOI
- https://doi.org/10.1016/j.jhepr.2025.101682
- Citations
- 1
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.32